Frank Svoboda Sells 20,000 Shares of Globe Life (NYSE:GL) Stock

Globe Life Inc. (NYSE:GL) CEO Frank Svoboda sold 20,000 shares of the business’s stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the sale, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. The trade was a 27.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Globe Life Stock Down 1.5%

GL stock opened at $154.39 on Thursday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life Inc. has a 1-year low of $116.73 and a 1-year high of $157.92. The firm has a fifty day moving average price of $148.25 and a two-hundred day moving average price of $142.48. The firm has a market cap of $11.99 billion, a price-to-earnings ratio of 10.68 and a beta of 0.50.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the firm earned $3.07 EPS. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Research analysts predict that Globe Life Inc. will post 15.57 EPS for the current year.

Globe Life Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be paid a dividend of $0.33 per share. The ex-dividend date is Monday, July 6th. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life’s payout ratio is presently 9.13%.

Hedge Funds Weigh In On Globe Life

Several hedge funds and other institutional investors have recently modified their holdings of GL. Allianz Asset Management GmbH grew its position in Globe Life by 55.2% in the 3rd quarter. Allianz Asset Management GmbH now owns 82,263 shares of the company’s stock valued at $11,761,000 after buying an additional 29,256 shares in the last quarter. Retirement Systems of Alabama acquired a new stake in Globe Life in the 3rd quarter valued at about $2,470,000. Pzena Investment Management LLC lifted its holdings in Globe Life by 5.6% in the 3rd quarter. Pzena Investment Management LLC now owns 998,506 shares of the company’s stock valued at $142,756,000 after acquiring an additional 52,523 shares during the last quarter. SG Americas Securities LLC lifted its holdings in Globe Life by 909.6% in the 4th quarter. SG Americas Securities LLC now owns 99,746 shares of the company’s stock valued at $13,950,000 after acquiring an additional 89,866 shares during the last quarter. Finally, Tudor Investment Corp ET AL acquired a new stake in Globe Life in the 3rd quarter valued at about $7,348,000. Institutional investors and hedge funds own 81.61% of the company’s stock.

Analysts Set New Price Targets

GL has been the subject of several recent research reports. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. Morgan Stanley boosted their price target on shares of Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, May 21st. Texas Capital raised shares of Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. Wells Fargo & Company boosted their price target on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a report on Friday, April 10th. Finally, Evercore set a $157.00 price target on shares of Globe Life in a report on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $174.11.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.